The western blotting analyses (Fig. 6A) showed the presence of high levels of LYZ in the cancer cells; in particular, an LYZ form at a high molecular weight (about 50 kDa) was observed, corresponding to the trimeric form of the protein. Here, LYZ is linked to cancer.